3 Noxious (i.e. painful or potentially tissue damaging) stimuli are sensed by specialized nerve cells, called peripheral or primary nociceptors, which connect the peripheral tissues with the spinal cord dorsal horn, the first site of synaptic processing in the pain pathway. From there, nociceptive signals are relayed to higher central nervous system areas where pain finally becomes conscious. It is generally accepted that chronic/pathological pain syndromes can originate from dysfunctions at all three levels. Persistent activity of peripheral nociceptors as well as plastic changes in the spinal and supra-spinal processing of nociceptive stimuli have been shown to contribute to these pathologies. In addition, these sites are also critically involved in the action of many analgesic drugs, in particular of opioids (Dickenson and Kieffer, 2006 ) but also of aspirin-like drugs (cyclooxygenase inhibitors) (Brune and Zeilhofer, 2006) . Constitutive (global) gene targeting has yielded important insights into mechanisms of pain and analgesia. It does however not allow spatial discrimination of these mechanisms at the different sites, although this was highly desirable in many aspects of basic pain research and analgesic drug development. One strategy to address this issue relies on conditional gene deletion through the Cre-loxP system. Primary nociceptor-specific gene deletion can be achieved with mice expressing the Cre recombinase under the transcriptional control of the gene encoding the sensory neuron-specific sodium channel (sns) Nav1.8 (Agarwal et al., 2004; Akopian et al., 1999) . Other mouse lines, Peripherin-Cre (Zhou et al., 2002) and HtPA-Cre (Pietri et al., 2003) , have been reported to express the Cre recombinase in primary sensory neurons of dorsal root ganglia. To further discriminate spinal (McGinnis and Krumlauf, 1992) . The expression of the Hoxb8 gene extends to the cervical segment C2 (Charité et al., 1995; Deschamps and Wijgerde, 1993) and thereby above makes Hoxb8 an appropriate gene to drive
Cre expression for brain-sparing gene deletion. Charité et al. (1995) characterized upstream cis-acting regulatory elements of the Hoxb8 gene and found that a 11kb DNA segment upstream of the Hoxb8 translational start was sufficient to closely mimic the endogenous Hoxb8 expression pattern. To generate Hoxb8-Cre transgenic mice, we fused the 11 kb DNA segment (Charité et al., 1995) to a Cre expression cassette and used this construct for pronuclear injections (figure 1A). Four transgenic founders were obtained each of which gave rise to a transgenic line. These mouse lines were back crossed continuously to the C57BL/6 background and maintained in a heterozygous state. Two lines (1403, 1404) showed the desired expression pattern on a gross scale depicted here at E9.5 and E11.5 (figure 1B). One of these lines (1403), which carries a single copy of the transgene ( figure 1C ), was characterized in detail and is described here. (Soriano, 1999) Hoxb8-Cre-mediated (conditional) deletion of the glycine transporter type 1 (GlyT1; Slc6a9) gene, which is abundantly expressed in spinal glial cells (Zafra et al., 1995) . Hoxb8-Cre mice were crossed with mice carrying floxed GlyT1 alleles (Yee et al, 2006) to generate Hoxb8-Cre
Immunohistochemical analysis of postnatal day 10 (P10) mice revealed intense GlyT1 immunofluorescence throughout the spinal grey matter of wild-type mice, but not in Hoxb8-GlyT1 -/-mice ( figure 3C ).
The mesodermic (vascular) expression pattern in the spinal cord was assessed with the use of the RA/EG reporter strain (Constien et al., 2001) , which carries a (Brett et al., 1993; Constien et al., 2001 ).
We next analyzed Hoxb8-Cre-induced lacZ expression in non-neural tissues (figure 4). Transverse sections through the lower hindlimb showed that the epidermis was devoid of Hoxb8-Cre-induced lacZ activity, while lacZ activity was found in cells scattered in the reticular dermis and the subcutis (figure 4A).
Striated muscle exhibited intense lacZ activity. Kidney sections showed strong lacZ activity in about half of the epithelial cells and in cells surrounding blood vessels (figure 4B), while liver and heart sections did not reveal any apparent lacZ staining ( figure 4C,D) .
Finally, the temporal onset of Hoxb8-induced Cre activity was analyzed in co- Hoxb8-Cre-induced lacZ expression pattern described here closely resembles that of endogenous Hoxb8 expression studied in wild-type embryos with in situ hybridization (Charité et al., 1995; Deschamps and Wijgerde, 1993) . A subtle difference exists however in the exact rostral expression boundary, which in the case of the endogenous Hoxb8 gene extends more rostrally up to C2 (Charité et al., 1995) . The rostral expression boundary of our Hoxb8-cre transgenic mice is located approximately two segments more posterior than the rostral limit of endogenous Hoxb8, presumably because of the lack on our construct of a retinoic acid-responsive element located in the Hox cluster between Hoxb4 and Hoxb5 (Oosterveen et al., 2003; Valarche et al., 1997) . Another difference became apparent when we compared the lacZ expression pattern of our Hoxb8-cre tg+ /R26R cotransgenic mice with published data on Hoxb8lacZ "knock-in" mice (Holstege et al., 2008) , in which the endogenous Hoxb8 had been replaced by a lacZ expression cassette. In postnatal (P11) Hoxb8lacZ mice, lacZ expression was less intense in the ventral than in the dorsal spinal cord and was found only in a subpopulation of DRG neurons (Holstege et al., 2008) . This difference reflects most likely the dynamic change in the expression of Hoxb8 transcripts during development, which is detectable in the Hoxb8lacZ mice but occluded through the irreversible lacZ activation in our mice. figure 5A ,B).
In summary, the Hoxb8-Cre transgenic mice described here exhibit the desired
Cre expression pattern and should hence be suitable for brain-sparing gene deletion experiments. This will be very helpful in the site-specific analysis e.g. of pain-related genes which often exhibit a wide-spread expression along the neural axis including peripheral, spinal and supraspinal sites. In such studies, our
Hoxb8-Cre mice will allow distinguishing supraspinal effects from those occurring at spinal and peripheral sites.
METHODS

Generation of Transgenic Construct and Mice
The Hoxb8-Cre transgene was built from the reporter construct no.1 used by Charité at al. (1995) . This construct contains a lacZ reporter gene fused in-frame to the first exon of Hoxb8, and about 11 kb of Hoxb8 upstream sequence including most of the Hoxb9, and the Hoxb9-Hoxb8 intergenic region. The 11.4 (Constien et al., 2001) and ROSA26lacZ reporter mouse lines (Soriano, 1999) .
The mice analyzed here had on average a C57BL/6 background of at least 93.75%.
Southern Blot Analysis
The number of Hoxb8-Cre transgene copies integrated into the genome of mouse line 1403 was determined using quantitative southern blot. A probe (749 bp) directed against the Hoxb8 promoter was generated by PCR using the 
LacZ Staining and Immunohistochemistry
To study the pattern of Cre activity the mouse lines were crossed with 2 reporter mouse lines, B6.129S4-Gt(ROSA)26Sor tm1Sor /J (ROSA26lacZ) (Soriano, 1999) and B6.129P2-Ager tm1Arnd (RA/EG) (Constien et al., 2001) , as well as with the use of mice carrying a floxed GlyT1 allele (GlyT1 fl/fl ; Slc6a9 tm1.1Bois ). Cotransgenic progeny (4 -7 weeks old) of Hoxb8-Cre and ROSA26-lacZ mice were histologically analyzed for β-galactosidase activity. Following decapitation of the mice, organs were rapidly removed, rinsed in ice cold phosphate buffered solution (PBS), embedded in dry ice and stored at -80°C. Fresh tissue was cut in 16 µm thick sections using a sliding microtome (HM 560; Micron, Heidelberg) at -20°C. Sections were placed on superfrost plus glass slides, dried at room temperature and fixed with 0.2% glutaraldehyde for 10 min on ice.
Counterstaining was performed with acidified (4% acetic acid) hematoxylin. All XGal stainings were performed at 37°C for 1 -24 hours. Whole-mount embryos (plug was considered as embryonic day E 0.5) were freed of their extraembryonic membranes before being fixed in 0.2% glutaraldehyde between 15 and 30 min on ice (for X-Gal staining protocols see Hogan et al., 1994) .
Presence of EGFP was detected through its endogenous fluorescence.
For immunostaining experiments, 4 -6 week old mice (10 day old mice for the GlyT1 stainings) were perfused transcardially through the ascending aorta with PBS followed by fixative containing 4% paraformaldehyde and 0.2% picric acid in 0.15 M phosphate buffer, pH 7.4. After perfusion, the organs were dissected out rapidly and post-fixed over night in the same fixative solution followed by 
